Ronald Muhlenkamp
Muhlenkamp & Co
Ronald Muhlenkamp Cameco Corp stake
total: 197
Muhlenkamp & Co CCJ trades
- Total transactions:
- 23
- New positions:
- 1
- Sold out:
- 1
- Added:
- 8
- Reduced:
- 13
- Held since:
- 2016 Q4
- Held for:
- 23 quarters
- Latest activity:
- 2023 Q2
According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any Cameco Corp (CCJ) shares. To date, the estimated cost basis is nearly $10.73 for "buy" trades and estimated average "sell" price is $14.68. Muhlenkamp & Co first purchased CCJ in 2016 Q4, initially acquiring 551,392 shares. Since the initial investment in Cameco Corp (CCJ), Muhlenkamp & Co has made 22 more transactions.
When did Ronald Muhlenkamp sell Cameco Corp (CCJ)?
Ronald Muhlenkamp sold off the entire Cameco Corp (CCJ) position in 2023 Q2.
When did Ronald Muhlenkamp buy Cameco Corp (CCJ)?
Ronald Muhlenkamp first invested in Cameco Corp (CCJ) in 2016 Q4 at the reported quarter-end price of $10.47 per share.
What's the cost basis of Muhlenkamp & Co's CCJ stake?
The estimated cost basis for Cameco Corp (CCJ) stake is around $10.73 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.73
- Weighted AVG sell price:
- $14.68
Ronald Muhlenkamp's historical trades in Cameco Corp
23 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.00%
|
0
|
$22.67
|
|
-100% (-161,964)
|
-1.56%
|
|
2022 Q4
|
1.56%
|
161,964
|
$22.67
|
$3,671,724
|
-0.10% (-159)
|
-0%
|
|
2022 Q3
|
1.92%
|
162,123
|
$26.51
|
$4,298,000
|
+0.35% (+558)
|
+0.01%
|
|
2022 Q2
|
1.59%
|
161,565
|
$21.02
|
$3,396,000
|
-0.37% (-603)
|
-0%
|
|
2022 Q1
|
1.64%
|
162,168
|
$29.10
|
$4,719,000
|
+0.78% (+1,252)
|
+0.01%
|
|
2021 Q4
|
1.22%
|
160,916
|
$21.81
|
$3,510,000
|
-57.18% (-214,859)
|
-1.8%
|
|
2021 Q3
|
3.14%
|
375,775
|
$21.73
|
$8,166,000
|
-1.00% (-3,810)
|
-0.03%
|
|
2021 Q2
|
2.67%
|
379,585
|
$19.18
|
$7,280,000
|
+1.01% (+3,810)
|
+0.03%
|
|
2021 Q1
|
2.23%
|
375,775
|
$16.07
|
$6,039,000
|
-2.28% (-8,776)
|
-0.06%
|
|
2020 Q4
|
2.07%
|
$13.40
|
+0.08% (+307)
|
|||
|
2020 Q3
|
2.01%
|
$10.10
|
+1.23% (+4,663)
|
|||
|
2020 Q2
|
2.08%
|
$10.25
|
-0.14% (-551)
|
|||
|
2019 Q4
|
1.48%
|
$8.90
|
-55.01% (-464,864)
|
|||
|
2019 Q3
|
3.91%
|
$9.50
|
+0.01% (+100)
|
|||
|
2019 Q2
|
4.41%
|
$10.73
|
-0.31% (-2,643)
|
|||
|
2019 Q1
|
4.73%
|
$11.79
|
-1.73% (-14,956)
|
|||
|
2018 Q3
|
4.23%
|
$11.40
|
-0.57% (-4,987)
|
|||
|
2018 Q1
|
2.88%
|
$9.09
|
+1.99% (+16,920)
|
|||
|
2017 Q4
|
2.42%
|
$9.23
|
-1.70% (-14,696)
|
|||
|
2017 Q3
|
2.78%
|
$9.67
|
-0.64% (-5,540)
|
|||
|
2017 Q2
|
2.60%
|
$9.10
|
-0.10% (-890)
|
|||
|
2017 Q1
|
3.13%
|
$11.07
|
+58.09% (+320,296)
|
|||
|
2016 Q4
|
1.93%
|
$10.47
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.